Oracle growth initiative gives CROs access to innovative Clinical One platform to spur adoption and improve trial efficiencies.
While increased investment in pharmaceutical research and development is creating more opportunities for Contract Research Organizations (CROs), many are struggling to keep pace with competitive pressures, changing market requirements, and a lack of skilled talent. To help CROs meet these challenges, Oracle introduced its CRO Growth Initiative in
'We're excited to join the CRO Growth Initiative,' said
'The CRO Growth Initiative is a way for CRO professionals to use Clinical One in a sandbox environment and experience its value firsthand,' said
Market shifts drive the need for a unified platform
According to
'As a growing CRO, we are excited that Oracle, Oracle's CRO Growth Initiative, and Clinical One are supporting our business goals to grow and address new markets,' said
Clinical One is the only truly unified eClinical platform that harmonizes data, streamlines workflow, and saves significant time from study startup to study closeout. It enables stakeholders to have quick and easy access to the data needed to support critical decision-making, patient safety, and study oversight. The platform integrates with legacy systems and wider application ecosystems, it can ingest any commonly used data source and format, and it can configure and scale for traditional, hybrid, or fully decentralized trials. Recently,
'FHI Clinical chose Oracle's Clinical One platform as our default clinical system because it is built the way we would have built for ourselves - single data source, unified platform, intuitive, and cost-efficient,' said
New independent studies that compare the performance of Clinical One against industry alternatives reveal its advantages:
Clinical One delivered electronic data capture (EDC) study build times more than 30% faster than industry alternatives.
For randomization and trial supply management (RTSM) builds, Clinical One was more than 70% faster.
Using EDC and RTSM together on Clinical One reduced build times by more than 65%. In real-world study conditions, organizations are gaining 6 to 9 weeks of actual time savings.
'Oracle's CRO Growth Initiative has elevated Oracle's commitment to CROs in reducing the barriers to adopting new technology to meet the needs of our customers, all at no risk to us,' said
'At Accelsiors, we pride ourselves to provide quality and expertise,' said
To see Clinical One in action and learn more about the CRO Growth Initiative, visit Oracle Health Sciences
Contact Info
Oracle, Corporate Communications
judi.palmer@oracle.com
+1 650 784 7901
About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.
(C) 2023 Electronic News Publishing, source